SIGNATURE ESTATE & INVESTMENT ADVISORS LLC RWK — INVESCO EXCH TRADED FD TR II

Ownership history in SIGNATURE ESTATE & INVESTMENT ADVISORS LLC  ·  9 quarters on record

AI Ownership Summary

SIGNATURE ESTATE & INVESTMENT ADVISORS LLC reported INVESCO EXCH TRADED FD TR II (RWK) in 9 quarterly 13F filings from 2024 Q2 through 2026 Q2. Peak portfolio weight reached 0.02% in 2024 Q4. The latest visible filing shows RWK at 0.01% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this RWK ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was SIGNATURE ESTATE & INVESTMENT ADVISORS LLC's position in INVESCO EXCH TRADED FD TR II, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q2

RWK was reported at 0.01% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.02% in 2024 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q2 to 2026 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How SIGNATURE ESTATE & INVESTMENT ADVISORS LLC held RWK — position size vs. price
% of Fund (quarterly)    RWK price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 9 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q2 ADDED — — — 5,682 +11 +0.2% 0.01% $831K 2026-07-14 $146.02
2026 Q1 ADDED — — — 5,671 +3 +0.1% 0.01% $727K 2026-04-15 $135.45
2025 Q4 ADDED — — — 5,668 +14 +0.2% 0.01% $717K 2026-02-06 $138.21
2025 Q3 ADDED — — — 5,654 +15 +0.3% 0.02% $707K 2025-11-05 $121.88
2025 Q2 ADDED — — — 5,639 +21 +0.4% 0.02% $659K 2025-07-29 $120.34
2025 Q1 ADDED — — — 5,618 +18 +0.3% 0.02% $606K 2025-05-16 $113.26
2024 Q4 ADDED — — — 5,600 +83 +1.5% 0.02% $651K 2025-02-11 $117.28
2024 Q3 ADDED — — — 5,517 +149 +2.8% 0.01% $642K 2024-11-06 $119.59
2024 Q2 INITIATED — — — 5,368 — — 0.01% $589K 2024-07-26 $111.88

FAQ About SIGNATURE ESTATE & INVESTMENT ADVISORS LLC and RWK

These are the practical questions this page is built to answer before you even open the full history table.

How long has SIGNATURE ESTATE & INVESTMENT ADVISORS LLC reported owning RWK?

SIGNATURE ESTATE & INVESTMENT ADVISORS LLC reported RWK across 9 quarterly 13F filings, from 2024 Q2 through 2026 Q2.

What was the largest reported RWK position in SIGNATURE ESTATE & INVESTMENT ADVISORS LLC's portfolio?

The largest reported portfolio weight for RWK was 0.02% in 2024 Q4.

What is the latest reported RWK position on this page?

The most recent filing on this page is 2026 Q2, when SIGNATURE ESTATE & INVESTMENT ADVISORS LLC reported 5,682 shares, equal to 0.01% of portfolio, with an estimated market value of $831K.

What does the chart on this RWK ownership page compare?

The chart compares SIGNATURE ESTATE & INVESTMENT ADVISORS LLC's quarterly RWK portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did SIGNATURE ESTATE & INVESTMENT ADVISORS LLC time their RWK position?

Based on 13F filing dates vs. subsequent RWK price moves, SIGNATURE ESTATE & INVESTMENT ADVISORS LLC correctly timed 5 out of 8 reported position changes (62%). The annualised alpha on RWK relative to SPY over the holding period was -4.0%.

← Back to SIGNATURE ESTATE & INVESTMENT ADVISORS LLC Holdings